Alto Neuroscience vs Axsome Therapeutics
Alto Neuroscience vs Axsome Therapeutics, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Alto Neuroscience is on 43/100 and Axsome Therapeutics on 9/100.
Where each one leads
Alto Neuroscience
- our overall score: 43/100 against 9/100
Axsome Therapeutics
- domain rating: 58/100 against 44/100
At a glance
| Measure | Alto Neuroscience | Axsome Therapeutics |
|---|---|---|
| What it is | Alto Neuroscience is a clinical-stage biopharmaceutical company developing precision psychiatry medicines for mental health conditions. | Biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders. |
| Category | Biotech, MedTech, HealthTech, Drug Discovery | Biotech, Pharmaceuticals, Healthcare |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | 2019 | 2012 |
| Headquarters | Los Altos, United States | New York, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Alto Neuroscience | Axsome Therapeutics |
|---|---|---|
| Employees | 86 | Not published |
| Total funding | $370M | Not published |
| Latest round | Registered Direct Offering | Post IPO |
| LinkedIn followers | 24,482 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Alto Neuroscience | Axsome Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 43/100 | 9/100 |
| Traction | 59/100 | Not published |
| Team | Not published | 30/100 |
| Community | 13/100 | Not published |
| Search visibility | 35/100 | 2/100 |
| Quality | 45/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | D (48/100) | D (46/100) |
| Domain ratingLink authority, 0-100 | 44/100 | 58/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Alto Neuroscience | Axsome Therapeutics |
|---|---|---|
| Hosting | Self Managed | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | WordPress | WordPress |
| Frameworks | Jquery | Jquery |
| Analytics | Google Analytics 4 | Google Tag Manager |
Alto Neuroscience vs Axsome Therapeutics: common questions
Which is better, Alto Neuroscience or Axsome Therapeutics?
On our 0-100 score Alto Neuroscience rates higher (43/100 against 9/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do Alto Neuroscience and Axsome Therapeutics compare on the numbers?
Alto Neuroscience leads on our overall score (43/100 against 9/100). Axsome Therapeutics leads on domain rating (58/100 against 44/100).
Read the full Alto Neuroscience review and pricing or the Axsome Therapeutics review and pricing. You can also browse other Alto Neuroscience alternatives we track.